ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Americas Devices — Revenue Growth YoY by Quarter
Americas Devices — Revenue Growth YoY (%) (%)
ResMed Americas Devices — Revenue Growth YoY: 6.0% in Q1 FY27, down 2.0 pts from a year earlier.
Latest, Q1 FY27
6.0%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-2.0 pts
8.0% in Q1 FY26
History
21 quarters
Since Q1 FY22
Sources
21
Documents cited below
Where the Q1 FY27 figure comes from
“Net revenue from devices for the three months ended September 30, 2026 increased to $720 million from $680 million for the three months ended September 30, 2025, an increase of $40 million or 6%, including an increase of 6% in the Americas and an increase of 6% in Rest of World (a 6% increase on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2026 increased by 6”
Source: ResMed SEC Filing (0000943819-26-000089) ↗
Reported in ResMed Form 8-K Revenue by Product and Region Tables.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Americas Devices — Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27CQ3 2026 | Sep 30, 2026 | 6.0% | -2.0 pts | ResMed SEC Filing (0000943819-26-000089) ↗ |
| Q4 FY26CQ2 2026 | Jun 30, 2026 | 6.0% | -1.0 pts | ResMed SEC Filing (0001193125-26-337962) ↗ |
| Q3 FY26CQ1 2026 | Mar 31, 2026 | 6.0% | 0.0 pts | ResMed SEC Filing (0001193125-26-197192) ↗ |
| Q2 FY26CQ4 2025 | Dec 31, 2025 | 8.0% | -4.0 pts | ResMed SEC Filing (0001193125-26-029326) ↗ |
| Q1 FY26CQ3 2025 | Sep 30, 2025 | 8.0% | -3.0 pts | ResMed SEC Filing (0001193125-25-258519) ↗ |
| Q4 FY25CQ2 2025 | Jun 30, 2025 | 7.0% | +2.0 pts | ResMed SEC Filing (0001193125-25-170512) ↗ |
| Q3 FY25CQ1 2025 | Mar 31, 2025 | 6.0% | -1.0 pts | ResMed SEC Filing (0001193125-25-091357) ↗ |
| Q2 FY25CQ4 2024 | Dec 31, 2024 | 12.0% | +5.0 pts | ResMed SEC Filing (0001193125-25-017218) ↗ |
| Q1 FY25CQ3 2024 | Sep 30, 2024 | 11.0% | +9.0 pts | ResMed SEC Filing (0001193125-24-242806) ↗ |
| Q4 FY24CQ2 2024 | Jun 30, 2024 | 5.0% | -25.0 pts | ResMed SEC Filing (0001193125-24-191487) ↗ |
| Q3 FY24CQ1 2024 | Mar 31, 2024 | 7.0% | -41.0 pts | ResMed SEC Filing (0001193125-24-113883) ↗ |
| Q2 FY24CQ4 2023 | Dec 31, 2023 | 7.0% | -34.0 pts | ResMed SEC Filing (0001193125-24-014223) ↗ |
| Q1 FY24CQ3 2023 | Sep 30, 2023 | 2.0% | -21.0 pts | ResMed SEC Filing (0001193125-23-264072) ↗ |
| Q4 FY23CQ2 2023 | Jun 30, 2023 | 30.0% | +19.0 pts | ResMed SEC Filing (0001193125-23-202850) ↗ |
| Q3 FY23CQ1 2023 | Mar 31, 2023 | 48.0% | +18.0 pts | ResMed SEC Filing (0001193125-23-122110) ↗ |
| Q2 FY23CQ4 2022 | Dec 31, 2022 | 41.0% | +22.0 pts | ResMed SEC Filing (0001193125-23-016231) ↗ |
| Q1 FY23CQ3 2022 | Sep 30, 2022 | 23.0% | -17.0 pts | ResMed SEC Filing (0001193125-22-270961) ↗ |
| Q4 FY22CQ2 2022 | Jun 30, 2022 | 11.0% | – | ResMed SEC Filing (0001193125-22-218522) ↗ |
| Q3 FY22CQ1 2022 | Mar 31, 2022 | 30.0% | – | ResMed SEC Filing (0001193125-22-127535) ↗ |
| Q2 FY22CQ4 2021 | Dec 31, 2021 | 19.0% | – | ResMed SEC Filing (0001193125-22-019765) ↗ |
| Q1 FY22CQ3 2021 | Sep 30, 2021 | 40.0% | – | ResMed SEC Filing (0001193125-21-311286) ↗ |
Cite this data
StockData. (2026). ResMed Americas Devices — Revenue Growth YoY (%), quarterly Q1 FY22–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-amer-yoy
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?